Episode Details
Back to Episodes
Skip Dolby, Buy Allegion & Arthur J. Gallagher
Published 2 days, 17 hours ago
Description
Dolby Laboratories, with its slow growth and high costs, is a stock to avoid. Meanwhile, Allegion and Arthur J. Gallagher, with their strong margins and growth, are primed for a rebound. Both trade at forward P/E ratios under sixteen, making them potential entry points for investors.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/e9cfee7c976adf39